1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma
- Contribution to journal › Article
-
Mark
Otitis media : Interactions between host and environment, immune and inflammatory responses
- Contribution to journal › Scientific review
- 2023
-
Mark
Exploring the microbial landscape uncovering the pathogens associated with community-acquired pneumonia in hospitalized patients
- Contribution to journal › Article
-
Mark
A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection
- Contribution to journal › Article
- 2022
-
Mark
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation
- Contribution to journal › Article
-
Mark
Structural Insights into Common and Host-Specific Receptor-Binding Mechanisms in Algal Picorna-like Viruses
- Contribution to journal › Article
-
Mark
Primordial Capsid and Spooled ssDNA Genome Structures Unravel Ancestral Events of Eukaryotic Viruses
- Contribution to journal › Article
- 2021
-
Mark
Att leva med bakterier : Möjligheter till ett levbart immunitärt liv
Hansson, Kristofer LU ; Lenander, Cecilia LU and Loodin, Henrik LU (2021)
- Book/Report › Anthology (editor)
-
Mark
TEG-pucken: föreställningar om en framtida sjukhusvistelse
(2021) p.143-156
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Introduktion: bakterier och virus i en ny tid
(2021) p.7-18
- Chapter in Book/Report/Conference proceeding › Book chapter
